Skip to content
PeptideTech
Cart

Home / Research library / IGF-1 DES

Peptides

IGF-1 DES: molecular data, studies & sources

IGF-1 DES is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular record not yet resolved

A sufficiently specific molecular record was not resolved for this name. Formula, molecular weight and structure are withheld until the exact sequence, salt or preparation can be verified.

MF: not assigned · MW: not assigned · Structure: not assigned

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

No matching human study was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

    Preclinical research, reviews & other publications

    Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

    1. Review · secondary evidence

      Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I.

      Ballard FJ, Wallace JC, Francis GL et al. · The international journal of biochemistry & cell biology · 1996

      PMID 8930132 · DOI: 10.1016/1357-2725(96)00056-8

    2. Preclinical / laboratory research

      IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection.

      Lemmey AB, Martin AA, Read LC et al. · The American journal of physiology · 1991

      PMID 1996625 · DOI: 10.1152/ajpendo.1991.260.2.E213

    3. Research publication · design requires review

      Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue.

      Crescioli C, Villari D, Forti G et al. · Molecular and cellular endocrinology · 2002

      PMID 12573816 · DOI: 10.1016/s0303-7207(02)00370-2

    4. Research publication · design requires review

      Des (1-3) IGF-I potently enhances differentiated cell growth in olfactory bulb organ culture.

      Russo VC, Werther GA · Growth factors (Chur, Switzerland) · 1994

      PMID 7779409 · DOI: 10.3109/08977199409011003

    5. Preclinical / laboratory research

      IGF-I and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass.

      Martin AA, Tomas FM, Owens PC et al. · The American journal of physiology · 1991

      PMID 1928375 · DOI: 10.1152/ajprenal.1991.261.4.F626

    IGF-1 DES supplier sources

    Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

    Compare all IGF-1 DES sizes, forms and supplier prices →

    SupplierRecorded packagesExample source listing
    Cenexa LabsUSD1mg Vial1 recorded offers1mg Vial · $74.99Checked Sep 16, 2026Supplier listing

    Reference sources & further reading

      The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

      Search for additional research

      These links run searches; their results have not been individually reviewed and can include unrelated compounds.

      Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

      Related research profiles